<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR21">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>San Miguel</surname>
    <given-names>JF</given-names>
   </name>
   <name>
    <surname>Schlag</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Khuageva</surname>
    <given-names>NK</given-names>
   </name>
   <name>
    <surname>Dimopoulos</surname>
    <given-names>MA</given-names>
   </name>
   <name>
    <surname>Shpilberg</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Kropff</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Spicka</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Petrucci</surname>
    <given-names>MT</given-names>
   </name>
   <name>
    <surname>Palumbo</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Samoilova</surname>
    <given-names>OS</given-names>
   </name>
   <name>
    <surname>Dmoszynska</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Abdulkadyrov</surname>
    <given-names>KM</given-names>
   </name>
   <name>
    <surname>Delforge</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Jiang</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Mateos</surname>
    <given-names>MV</given-names>
   </name>
   <name>
    <surname>Anderson</surname>
    <given-names>KC</given-names>
   </name>
   <name>
    <surname>Esseltine</surname>
    <given-names>DL</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Deraedt</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Cakana</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>van de Velde</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Richardson</surname>
    <given-names>PG</given-names>
   </name>
  </person-group>
  <article-title>Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma</article-title>
  <source>J Clin Oncol Off J Am Soc Clin Oncol</source>
  <year>2013</year>
  <volume>31</volume>
  <fpage>448</fpage>
  <lpage>455</lpage>
  <pub-id pub-id-type="doi">10.1200/JCO.2012.41.6180</pub-id>
 </element-citation>
</ref>
